Research in this U19 Program is dependent on a system of central, standardized, and innovative analyses of West Nile virus (WNV) infection in cultured cells and in mice. The Virology Core is designed to meet these needs and standards and to provide infrastructure support for conducting WNV infections and virologic analysis for all five research projects of the Program. The Virology Core will be directed by Dr. Yueh-Ming Loo, an experienced virologist, biosafety expert, and a professional in the use of mice for virus infection studies. The Virology core will 1) Produce, conduct quality control, and conduct studies of centralized virus stocks used by the Program, 2) Coordinate and conduct all mouse infection studies within the Program, 3) Conduct in vitro and in vivo virologic analyses for the Program, and 4) Conduct and coordinate biosafety training of the Program staff. The Virology Core will be located in a centralized facility containing a suite of biosafety rooms for tissue culture and infected animal housing under and work under biosafety level 3 practices. The Core will work closely with Project Leaders and staff to design infection studies and conduct virologic analysis in support of the proposed studies. The Core will provide services of virus and virus product quantification, virus construction and characterization, serologic analyses, molecular diagnostic and quantification analyses, in vitro and in vivo infection support and analysis, and animal monitoring, clinical scoring, and the harvesting and possessing of tissues and cell samples. The Virology Core will interface with the Administrative Core to maintain records and training of personnel, prepare reports, and to communicate with Program staff.
Reliable virologic analyses are essential for understanding mechanisms of immune control of virus infection. The Virology Core wills serve as the central and essential facility to conduct virologic and infection analyses within the proposed studies of the U19 Program, and will contribute to a greater understanding of flavivirus/host interactions that control infection and immunity.
|Adams Waldorf, Kristina M; Stencel-Baerenwald, Jennifer E; Kapur, Raj P et al. (2016) Fetal brain lesions after subcutaneous inoculation of Zika virus in a pregnant nonhuman primate. Nat Med 22:1256-1259|
|Miner, Jonathan J; Diamond, Michael S (2016) Mechanisms of restriction of viral neuroinvasion at the blood-brain barrier. Curr Opin Immunol 38:18-23|
|Hare, David N; Collins, Susan E; Mukherjee, Subhendu et al. (2016) Membrane Perturbation-Associated Ca2+ Signaling and Incoming Genome Sensing Are Required for the Host Response to Low-Level Enveloped Virus Particle Entry. J Virol 90:3018-27|
|Pattabhi, Sowmya; Wilkins, Courtney R; Dong, Ran et al. (2016) Targeting Innate Immunity for Antiviral Therapy through Small Molecule Agonists of the RLR Pathway. J Virol 90:2372-87|
|Gorman, Matthew J; Poddar, Subhajit; Farzan, Michael et al. (2016) The Interferon-Stimulated Gene Ifitm3 Restricts West Nile Virus Infection and Pathogenesis. J Virol 90:8212-25|
|Green, Richard; Wilkins, Courtney; Thomas, Sunil et al. (2016) Transcriptional profiles of WNV neurovirulence in a genetically diverse Collaborative Cross population. Genom Data 10:137-140|
|Proenca-Modena, Jose Luiz; Hyde, Jennifer L; Sesti-Costa, Renata et al. (2016) Interferon-Regulatory Factor 5-Dependent Signaling Restricts Orthobunyavirus Dissemination to the Central Nervous System. J Virol 90:189-205|
|Salimi, Hamid; Cain, Matthew D; Klein, Robyn S (2016) Encephalitic Arboviruses: Emergence, Clinical Presentation, and Neuropathogenesis. Neurotherapeutics 13:514-34|
|Vasek, Michael J; Garber, Charise; Dorsey, Denise et al. (2016) A complement-microglial axis drives synapse loss during virus-induced memory impairment. Nature 534:538-43|
|Zhang, Rong; Miner, Jonathan J; Gorman, Matthew J et al. (2016) A CRISPR screen defines a signal peptide processing pathway required by flaviviruses. Nature 535:164-8|
Showing the most recent 10 out of 96 publications